  | MAWET, M., Chabbert Buffet, N., Gerard, M., Nisolle, M., Kridelka, F., & Pintiaux, A. (September 2022). Nouveautés en contraception intra-utérine. Revue Médicale de Liège, 77 (9), 521 - 526.  Editorial Reviewed verified by ORBi |
Mawet, M. (12 March 2022). Le Syndrome de HAIRAN, Une forme extrême des ovaires micro-polykystiques [Paper presentation]. Symposium du CRGOLFB. |
  | Perrier d'Hauterive, S., Close, R., Gridelet, V., Mawet, M., Nisolle, M., & Geenen, V. (25 January 2022). Human Chorionic Gonadotropin and Early Embryogenesis: Review. International Journal of Molecular Sciences, 23, 1380. doi:10.3390/ijms23031380 Peer Reviewed verified by ORBi |
 | Mawet, M., NECHIFOR - POTORAC, I., BECKERS, A., KRIDELKA, F., & PINTIAUX, A. (December 2021). Comment j’explore…une hyperandrogénie dans un contexte d’insulinorésistance. Un exemple basé sur le syndrome HAIR-AN. Revue Médicale de Liège, 76 (12), 890-895. Editorial Reviewed verified by ORBi |
 | Mawet, M., Perrier d'Hauterive, S., HENRY, L., Potorac, I., Kridelka, F., Nisolle, M., & Pintiaux, A. (2021). Restoration of Fertility in Patients with Spontaneous Premature Ovarian Insufficiency: New Techniques under the Microscope. Journal of Clinical Medicine, 10 (23). doi:10.3390/jcm10235647 Peer Reviewed verified by ORBi |
 | Mawet, M. (2020). Estetrol (E4), the fourth natural estrogen, molecular and clinical aspects [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/290573 |
 | GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause (New York, N.Y.), 27 (8), 848-857. doi:10.1097/GME.0000000000001561 Peer reviewed |
 | Apter, D., Zimmerman, Y., Beekman, L., Mawet, M., Maillard, C., Foidart, J.-M., & Coelingh Bennink, H. J. T. (2017). Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control. European Journal of Contraception and Reproductive Health Care, 22 (4), 260-267. doi:10.1080/13625187.2017.1336532 Peer Reviewed verified by ORBi |
 | Kluft, C., Zimmerman, Y., Mawet, M., Klipping, C., Duijkers, I. J. M., Neuteboom, J., Foidart, J.-M., & Bennink, H. C. (2017). Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol. Contraception, 95 (2), 140-147. doi:10.1016/j.contraception.2016.08.018 Peer Reviewed verified by ORBi |
 | Apter, D., Zimmerman, Y., Beekman, L., Mawet, M., Maillard, C., Foidart, J.-M., & Coelingh Bennink, H. (2016). Bleeding Pattern and Cycle Control With Estetrol-Containing Combined Oral Contraceptives: Results From a Phase II, Randomised, Dose-Finding Study (FIESTA). Contraception. doi:10.1016/j.contraception.2016.04.015 Peer Reviewed verified by ORBi |
 | NEUPREZ, A., Delcour, J.-P., Fatemi, F., GILLET, P., Mawet, M., François, G., Bruyère, O., CRIELAARD, J.-M., Gosset, C., & Reginster, J.-Y. (2015). Development and validation of the French version of a tool assessing patient's expectations in lower limb osteoarthritis. Journal of Orthopaedics, 12, 46-57. doi:10.1016/j.jor.2014.06.002 Peer Reviewed verified by ORBi |
 | Mawet, M., Maillard, C., Klipping, C., Zimmerman, Y., Foidart, J.-M., & Bennink, H. J. T. C. (2015). Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. European Journal of Contraception and Reproductive Health Care, 20 (6), 463-475. doi:10.3109/13625187.2015.1068934 Peer Reviewed verified by ORBi |
 | Duijkers, I. J. M., Klipping, C., Zimmerman, Y., Appels, N., Jost, M., Maillard, C., Mawet, M., Foidart, J.-M., & Bennink, H. J. T. C. (2015). Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study. European Journal of Contraception and Reproductive Health Care, 20 (6), 476-489. doi:10.3109/13625187.2015.1074675 Peer Reviewed verified by ORBi |
 | Mawet, M., Nollevaux, F., Nizet, D., Wijzen, F., Gordenne, V., Tasev, N., Segedi, D., Marinescu, B., Enache, A., Parhomenko, V., Frankenne, F., & Foidart, J.-M. (2014). Impact of a New Levonorgestrel Intrauterine System, Levosert(®), on Heavy Menstrual Bleeding: Results of a One-Year Randomised Controlled Trial. European Journal of Contraception and Reproductive Health Care. doi:10.3109/13625187.2014.894184 Peer Reviewed verified by ORBi |